Chronic nausea

Reading File

Finding Sources

Searching PubMed

"chronic nausea"[MeSH Terms] AND management

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive information to provide a thorough answer on chronic nausea. Let me compile this into a well-organized response.

Chronic Nausea

Chronic nausea is defined as nausea lasting more than 7 days. It is one of the more diagnostically challenging symptoms in medicine because it originates from neuroanatomical pathways converging from the GI tract, CNS, vestibular system, metabolic processes, and medications - and the same symptom can arise from vastly different underlying conditions.

Pathophysiology

The final common pathway is the emetic center (dorsolateral reticular formation of the medulla), which receives afferent signals from:

GI tract and oropharynx
Chemoreceptor trigger zone (area postrema)
Vestibular system
Cerebral cortex
Heart and musculoskeletal system

Key neurotransmitters involved: histamine, dopamine, serotonin (5-HT3), NK1/substance P, acetylcholine, cortisol, norepinephrine, vasopressin. This pharmacological diversity underpins the many different antiemetic drug classes.

Mild stimulation of these pathways produces nausea; intense stimulation produces vomiting. Individual thresholds for nausea are dynamic and modifiable by anxiety, anticipation, and adaptation.

Yamada's Textbook of Gastroenterology, 7th ed.

Causes of Chronic Nausea

Mechanical / Structural

Gastric or small bowel obstruction
Superior mesenteric artery (SMA) syndrome - duodenal compression from weight loss, bed rest, or post-surgery
Gastric volvulus, intussusception, antral web
Median arcuate ligament syndrome (MALS)

Mucosal Inflammation

Peptic ulcer disease / gastritis
Crohn's disease
Pancreatitis (acute or chronic)
Cholecystitis, hepatitis, appendicitis

Motility Disorders

Gastroparesis - the most studied; >90% of patients report nausea, 68-84% have vomiting; causes include diabetes (27-65% of long-standing T1DM), post-surgical vagotomy, connective tissue disease, idiopathic
Functional dyspepsia - nausea especially in the postprandial period
Chronic intestinal pseudoobstruction (CIP)

Functional Gastroduodenal Disorders (Rome IV)

Chronic Nausea and Vomiting Syndrome (CNVS) - replaces older terms "chronic idiopathic nausea" and "functional vomiting"; requires bothersome nausea ≥1 day/week and/or ≥1 vomiting episode/week, for at least 3 months, with onset ≥6 months prior, and no organic cause on routine investigations including endoscopy
Cyclic Vomiting Syndrome (CVS) - stereotypical acute episodes lasting <1 week, ≥3 in the prior year; strong association with migraine history; mean onset age 30-35 in adults, ~5 years in children; diagnosis delayed an average of 5-6 years
Cannabinoid Hyperemesis Syndrome (CHS) - CVS-like episodes from prolonged cannabis use; pathognomonic relief by sustained cessation; associated with compulsive hot bathing/showering
Rumination syndrome - effortless regurgitation of recently ingested food, not preceded by retching; 33% of patients with unexplained nausea/vomiting meet criteria

CNS and Peripheral Neural

Intracranial malignancy, infarction, hemorrhage, infection
Migraine headaches
Motion sickness / labyrinthine disease
Autonomic neuropathy
Pseudotumor cerebri

Metabolic and Endocrine

Diabetes (gastroparesis, DKA)
Uremia / chronic renal insufficiency
Adrenal insufficiency
Thyroid disorders (hypo- or hyperthyroidism)
Acute fatty liver of pregnancy

Medications (very common)

Agents producing chronic nausea include: NSAIDs, opioids, antibiotics, digoxin, antiarrhythmics, oral contraceptives, chemotherapy, and many others. Symptoms typically begin shortly after initiating therapy.

Other

Pregnancy (nausea of pregnancy / hyperemesis gravidarum)
Post-chemotherapy / radiation
Cardiac disease (MI, heart failure)
Psychiatric: anxiety, depression, eating disorders
Yamada's Gastroenterology, 7th ed. | Harrison's Principles of Internal Medicine, 22nd ed.

Evaluation / Diagnostic Workup

Step 1 - History: Establish timeline. Acute (≤7 days) vs. chronic (>7 days). Character, timing relative to meals, relieving/aggravating factors, medications, cannabis use, weight loss, associated symptoms.

Step 2 - Exclude non-GI causes first: Medications, renal insufficiency, cardiac disease, vestibular disorders, neurologic disease.

Step 3 - Labs: Electrolytes (hypokalemia, metabolic alkalosis from vomiting), CBC (iron-deficiency anemia suggests mucosal cause), LFTs, pancreatic enzymes, thyroid function, renal function. Hormone levels or serologies if endocrinologic, rheumatologic, or paraneoplastic causes suspected.

Step 4 - Imaging:

Abdominal X-ray: air-fluid levels for obstruction; diffuse dilation for ileus
Upper endoscopy: ulcers, malignancy, food retention (gastroparesis)
CT abdomen: partial bowel obstruction, bowel wall disease
CT/MRI enterography: Crohn's disease
Ultrasound: biliary causes
Brain CT/MRI: if intracranial pathology suspected

Step 5 - Motility testing (if above non-diagnostic):

Gastric scintigraphy - standard for gastroparesis diagnosis; ¹³C-labeled breath test is a non-radioactive alternative
Small-intestinal manometry: distinguishes neuropathic vs myopathic pseudoobstruction
Esophageal pH monitoring: nausea as atypical GERD presentation
pH/impedance + high-resolution manometry: diagnoses rumination syndrome
Impedance planimetry: detects reduced pyloric distensibility in gastroparesis
Harrison's Principles, 22nd ed.

Treatment

General Principles

Correct remediable causes (stop offending medications, optimize glycemic control in diabetics)
Rehydrate if needed (IV if oral intake unsustainable)
Restart oral feeds with low-fat liquids, then low-residue small-particle diet
Low-fat, small-particle diets have shown durable efficacy in gastroparesis

Pharmacological: Antiemetics

Drug Class	Mechanism	Examples	Indications
Anticholinergic / Antihistamine	Vestibular pathway blockade	Dimenhydrinate, meclizine, scopolamine	Motion sickness, inner ear disease
D2 antagonists (prokinetics)	Area postrema blockade, gastric motility	Metoclopramide, prochlorperazine, domperidone	Gastroparesis, medication/toxin-induced, functional dyspepsia
5-HT3 antagonists	Serotonin receptor blockade	Ondansetron, granisetron	Post-operative, chemotherapy, radiation
5-HT4 agonists	Prokinetic	Cisapride (withdrawn), mosapride	Gastroparesis
NK1 antagonists	Substance P blockade	Aprepitant, fosaprepitant	Chemotherapy-induced
Cannabinoids	CNS	Dronabinol, nabilone	Chemotherapy-induced
Tricyclic antidepressants	Multiple CNS	Nortriptyline, amitriptyline	Functional nausea (CNVS), CVS

Metoclopramide is the most studied prokinetic for gastroparesis. Note: dopamine antagonists carry a risk of tardive dyskinesia with long-term use - the FDA limits metoclopramide use to <12 weeks at standard doses.

Harrison's Principles, 22nd ed.

For CNVS Specifically

Management is extrapolated from functional dyspepsia and functional vomiting trials:

Tricyclic antidepressants (low-dose amitriptyline or nortriptyline) are first-line
Anxiolytics and behavioral therapy for patients with prominent psychological comorbidity
Dietary modifications: small, frequent, low-fat meals

For CVS

Prophylaxis: Tricyclic antidepressants (amitriptyline), topiramate, cyproheptadine (especially in children)
Abortive therapy: Triptans (sumatriptan), ondansetron, lorazepam
Migraine-style management given strong pathophysiological overlap

For CHS

The only definitive treatment is complete cannabis cessation
Topical capsaicin cream applied to the abdomen provides acute relief during episodes (reduces substance P locally)
Hot showers/baths provide temporary symptomatic relief but are not recommended as primary therapy

Advanced Therapies for Refractory Gastroparesis

Gastric electrical stimulation (Enterra): FDA-approved as a humanitarian use device for refractory diabetic or idiopathic gastroparesis. Reduces nausea/vomiting in large uncontrolled series; diabetics respond better than idiopathic cases; pain and chronic opioid use predict poor response. Controlled trials show inconsistent benefit.
Gastric pyloroplasty / pyloric POEM: Small series show benefit; POEM is endoscopic and outpatient; large RCTs lacking
Surgical pyloroplasty: Retrospective series show improvement in up to 80% of gastroparetics
Nutritional support: Enteral feeding for severe cases; TPN as a last resort; venting gastrostomy for gas/fluid release

For CIP (Chronic Intestinal Pseudoobstruction)

Pyridostigmine or erythromycin for small bowel prokinesis
Octreotide 25-200 mcg SC at bedtime to promote migrating motor complexes
Antibiotics for bacterial overgrowth

Complementary Approaches

Ginger (Zingiber officinale): Shown superior to placebo and equivalent to metoclopramide for postoperative nausea; effective for morning sickness and chemotherapy-induced nausea at 0.5-1 g/day. Caution: inhibits platelet aggregation (increased bleeding risk with anticoagulants/antiplatelets).
Pyridoxine (B6): Used for nausea of pregnancy; mixed RCT evidence
Acupressure at the P6 (Neiguan) point
Relaxation techniques / behavioral therapy
Yamada's Gastroenterology, 7th ed. | Sleisenger and Fordtran's GI and Liver Disease

Red Flags Warranting Urgent Workup

Weight loss > 5% body weight
Progressive dysphagia
Hematemesis or melena
Palpable abdominal mass
New onset in patients >50 years
Neurological symptoms (headache, visual changes, focal deficits)
Signs of obstruction (abdominal distension, absence of flatus)

Summary

Chronic nausea requires a systematic approach: first rule out medications and non-GI systemic causes, then evaluate the GI tract structurally (endoscopy, imaging), then functionally (motility testing). The Rome IV framework classifies functional causes (CNVS, CVS, CHS, rumination). Treatment is cause-directed when possible, with antiemetics, prokinetics, dietary modification, and - for functional disorders - neuromodulators (TCAs) as the main tools.

This is a shared conversation. Sign in to Orris to start your own chat.